Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction
NCT07252401Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Randomised trial of terlipressin in Variceal bleeding and chronic kidney disease (CKD) (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Renal function recovery at 6 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
terlipressin
03
Conditions
Variceal bleedingchronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07252401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252401.